Catalyst
Slingshot members are tracking this event:
Phase 1 Clinical Trial for ATI-50001 Initiated, an Investigational JAK Inhibitor, for the Treatment of Alopecia Totalis and Alopecia Universalis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ACRS | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 07, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ati-50001, Jak Inhibitor, Alopecia Areata, Ati-50002
